9 June 2020 NASA’s Jet Propulsion Laboratory has selected Planet Innovation as the only Australian manufacturer of a new ventilator tailored for COVID-19 patients. PI is among 13 international companies and eight U.S. manufacturers selected from more than…
5 June 2020 • CSL appointed Trusted Manufacturer for University of Queensland’s “molecular clamp” enabled COVID-19 vaccine candidate • CEPI and CSL will share costs associated with the clinical development and manufacture of the vaccine candidate • A…
4 June 2020 An innovative research partnership has been established between Monash University and new Melbourne-based start up, oNKo-innate Pty Ltd. The unique partnership sees oNKo-innate, co-founded by Professor Nicholas Huntington and Dr Jai Rautela, being based at the Monash Biomedicine Discovery…
4 June 2020 A world-first therapeutic for treating sleep apnea and a range of other weak muscle conditions will be unveiled this month at global biotech innovation event, BIO Digital. Developed by RMIT in collaboration with Snoretox Pty…
4 June 2020 Researchers from CSIRO, Australia’s national science agency, have made it possible to 3D print tailor-made stents, a critical biomedical device used to treat narrow or blocked arteries. The breakthrough, made in partnership with Wollongong-based Medical…
2 June 2020 The Morrison Government is investing $66 million into finding a vaccine and treatments for COVID-19, as well as better preparing for future pandemics. This research will enable Australia’s world-class researchers to contribute to global efforts…
2 June 2020 The Australian Government will invest $3M in Walter and Eliza Hall Institute research programs that are developing new classes of medicines for COVID-19. The funding from the Medical Research Future Fund (MRFF) will support…
2 June 2020 Melbourne and Sydney, Australia – Atmo Biosciences, a digital health business which provides objective real-time insights into gut health and microbiome function, has raised a further A$2.5 million in an oversubscribed funding round, supplementing an…
4 June 2020 Global platform trial taps Australian drug for major global COVID-19 treatment study As the world mobilises to bring to bear the full scientific resources it can to fight the COVID-19 pandemic, an Australian biotech…
1 June 2020 AbbVie, a research-based global biopharmaceutical company, and Jacobio Pharmaceuticals, a clinical-stage pharmaceutical company, today announced a global, strategic collaboration to develop and commercialize SHP2 inhibitors, which target a key node in cancer and immune cells. SHP2 is…
21 May 2020 Certara®, the global leader in model-informed drug development and regulatory science announced the appointments of Terrance (Terry) Ocheltree, Ph.D., R.Ph. as vice president of regulatory strategy and chemistry, manufacturing and controls (CMC) and Lynne Georgopoulos,…
2 June 2020 Diabetes treatments could be improved following the development of a dramatically modified form of human insulin, called ‘Mini-Ins’, that successfully mimics the ultra-fast-acting properties of cone snail venom insulin. Mini-Ins has demonstrated significant promise…